Tag: ABK Biomedical
ABK Biomedical announce first patient treated in Y90 radioembolization study
ABK Biomedical, a medical device company dedicated to the research, development, and commercialisation of advanced imageable embolic medical devices, has announced the first...
ABK Biomedical announces IDE approval for multicentre pivotal study of Eye90...
ABK Biomedical has received approval for its investigational device exemption (IDE) application from the US Food and Drug Administration (FDA) to commence a multicentre...
ABK Biomedical announces FDA 510(k) clearance of Easi-Vue embolic microspheres for...
ABK Biomedical has announced US Food and Drug Administration (FDA) 510(k) clearance of Easi-Vue embolic microspheres for the treatment of patients suffering from arteriovenous...
ABK Biomedical appoints Michael J Mangano as president and CEO
ABK Biomedical, a company dedicated to the research, development and commercialisation of innovative embolic therapies, has announced the appointment of Michael J Mangano as...
